Cyclacel Pharmaceuticals Inc.
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 21 institutions reported holding Cyclacel Pharmaceuticals Inc. in their 13F filings, up 3 from Q4 2024. 4 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($354K), Shay Capital LLC ($31K) and Geode Capital Management, LLC ($17K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Cyclacel Pharmaceuticals Inc.
- CUSIP
- 23254L801
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $54K |
| Exits | 1 | $5K |
All 13F filers, Q4 2024 → Q1 2025: 949,082 shares bought and 26,647 shares sold, net +922,435 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Armistice Capital, LLC | 0.01% | Add +118.7% | 1,269,485 | $354K |
| Shay Capital LLC | 0.01% | New | 110,919 | $31K |
| Geode Capital Management, LLC | 0.00% | Add +477.5% | 62,467 | $17K |
| UBS Group AG | 0.00% | Add +31.6% | 62,249 | $17K |
| Citadel Advisors | 0.00% | New | 51,921 | $14K |
| Two Sigma Securities, LLC | 0.00% | Reduce -43.3% | 16,218 | $5K |
| Point72 Asset Management | 0.00% | No change | 15,333 | $4K |
| Two Sigma Investments, LP | 0.00% | New | 15,286 | $4K |
| XTX Topco Ltd | 0.00% | New | 14,285 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +11.8% | 6,255 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +49.9% | 1,202 | $336 |
| Financial Gravity Asset Management, Inc. | 0.00% | — | 200 | $56 |
| Archer Investment Corp | 0.00% | No change | 200 | $56 |
| Activest Wealth Management | 0.00% | No change | 133 | $37 |
| Osaic Holdings, Inc. | 0.00% | No change | 126 | $34 |
| Morgan Stanley | 0.00% | No change | 80 | $22 |
| Bank of America Corp. | 0.00% | Add +5.9% | 54 | $15 |
| Wells Fargo & Company | 0.00% | No change | 33 | $9 |
| Signaturefd, LLC | 0.00% | No change | 20 | $6 |
| Harbour Investments, Inc. | 0.00% | No change | 13 | $4 |
| Danske Bank A/S | 0.00% | No change | 2 | $1 |
"% of holder's portfolio" is CYCLACEL PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Cyclacel Pharmaceuticals Inc. the manager owns.